Literature DB >> 33685528

Recombinant human epidermal growth factor combined with vacuum sealing drainage for wound healing in Bama pigs.

Shuai Wei1,2,3, Wei Wang4, Li Li5, Hao-Ye Meng1, Chun-Zhen Feng6, Yu-Ying Dong7, Xi-Chi Fang8, Qi-Qiang Dong9, Wen Jiang10, Hai-Li Xin11, Zhan-Zhen Li12, Xin Wang13,14.   

Abstract

BACKGROUND: Vacuum sealing drainage (VSD) and epidermal growth factor (EGF) both play an important role in the treatment of wounds. This study aims to explore the effects of the combination of VSD and EGF on wound healing and the optimal concentration and time of EGF.
METHODS: We tested the proliferation and migration capacity of HaCaT and L929 cells at different EGF concentrations (0, 1, 5, 10, and 100 ng/ml) and different EGF action times (2, 10, and 30 min). A full-thickness skin defect model was established using male, 30-week-old Bama pigs. The experiment included groups as follows: routine dressing change after covering with sterile auxiliary material (Control), continuous negative pressure drainage of the wound (VSD), continuous negative pressure drainage of the wound and injection of EGF 10 min followed by removal by continuous lavage (V + E 10 min), and continuous negative pressure drainage of the wound and injection of EGF 30 min followed by removal by continuous lavage (V + E 30 min). The wound healing rate, histological repair effect and collagen deposition were compared among the four groups.
RESULTS: An EGF concentration of 10 ng/ml and an action time of 10 min had optimal effects on the proliferation and migration capacities of HaCaT and L929 cells. The drug dispersion effect was better than drug infusion after bolus injection effect, and the contact surface was wider. Compared with other groups, the V + E 10 min group promoted wound healing to the greatest extent and obtained the best histological score.
CONCLUSIONS: A recombinant human epidermal growth factor (rhEGF) concentration of 10 ng/ml can promote the proliferation and migration of epithelial cells and fibroblasts to the greatest extent in vitro. VSD combined with rhEGF kept in place for 10 min and then washed, can promote wound healing better than the other treatments in vivo.

Entities:  

Keywords:  Epidermal growth factor; Full-thickness skin defect; Skin wound healing; Vacuum sealing drainage

Mesh:

Substances:

Year:  2021        PMID: 33685528      PMCID: PMC7941968          DOI: 10.1186/s40779-021-00308-5

Source DB:  PubMed          Journal:  Mil Med Res        ISSN: 2054-9369


  46 in total

1.  Experimental study of a newly developed bilayer artificial skin.

Authors:  S Suzuki; K Matsuda; N Isshiki; Y Tamada; Y Ikada
Journal:  Biomaterials       Date:  1990-07       Impact factor: 12.479

2.  [Impact of vacuum-assisted closure management in deep neck abscesses].

Authors:  Luis Humberto Govea-Camacho; Andrea Astudillo-Carrera; José Manuel Hermosillo-Sandoval; Sergio Rodríguez-Reynoso; Alejandro González-Ojeda; Clotilde Fuentes-Orozco
Journal:  Cir Cir       Date:  2016-02-21       Impact factor: 0.361

Review 3.  Epidermal growth factor in the treatment of diabetic foot ulcers: an update.

Authors:  Elisavet K Tiaka; Nikolaos Papanas; Anastassios C Manolakis; George S Georgiadis
Journal:  Perspect Vasc Surg Endovasc Ther       Date:  2012-04-11

4.  In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF).

Authors:  Ji Suk Choi; Kam W Leong; Hyuk Sang Yoo
Journal:  Biomaterials       Date:  2007-11-07       Impact factor: 12.479

5.  [Vacuum sealing as treatment of soft tissue damage in open fractures].

Authors:  W Fleischmann; W Strecker; M Bombelli; L Kinzl
Journal:  Unfallchirurg       Date:  1993-09       Impact factor: 1.000

Review 6.  Epidermal growth factor therapy and wound healing--past, present and future perspectives.

Authors:  J Hardwicke; D Schmaljohann; D Boyce; D Thomas
Journal:  Surgeon       Date:  2008-06       Impact factor: 2.392

7.  Initial multi-centre observations upon the effect of a new Topical Negative Pressure device upon patient and clinician experience and the treatment of wounds.

Authors:  Wojciech Witkowski; Arkadiusz Jawien; Wojciech Witkiewicz; Bartlomiej Zon
Journal:  Int Wound J       Date:  2009-04       Impact factor: 3.315

8.  A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial.

Authors:  G González; T Crombet; M Catalá; V Mirabal; J C Hernández; Y González; P Marinello; G Guillén; A Lage
Journal:  Ann Oncol       Date:  1998-04       Impact factor: 32.976

9.  Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction.

Authors:  Ariana García Ojalvo; Jorge Berlanga Acosta; Yssel Mendoza Marí; Maday Fernández Mayola; Calixto Valdés Pérez; William Savigne Gutiérrez; Ileydis Iglesias Marichal; Eduardo Álvarez Seijas; Alicia Molina Kautzman; Angélica Estrada Pacheco; David G Armstrong
Journal:  Int Wound J       Date:  2016-03-22       Impact factor: 3.315

10.  In Vivo Biocompatibility of Electrospun Biodegradable Dual Carrier (Antibiotic + Growth Factor) in a Mouse Model-Implications for Rapid Wound Healing.

Authors:  Charu Dwivedi; Himanshu Pandey; Avinash C Pandey; Sandip Patil; Pramod W Ramteke; Peter Laux; Andreas Luch; Ajay Vikram Singh
Journal:  Pharmaceutics       Date:  2019-04-14       Impact factor: 6.321

View more
  5 in total

1.  Application of negative pressure sealing drainage technology combined with silver ion sterilization nursing solution in the nursing of necrotizing fasciitis.

Authors:  Feng Chen; Changqing Liu
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

2.  Pushing the frontiers of military medical excellence: updates, progress and future needs.

Authors:  Jun Jie Seah; De-Yun Wang
Journal:  Mil Med Res       Date:  2022-06-10

3.  Vacuum sealing drainage combined with naso-intestinal and gastric decompression tubes for the treatment of esophagogastrostomy neck fistula.

Authors:  Chuan Tian; Kaihao Xu; Yanan Zhao; Yahua Li; Kunpeng Wu; Dechao Jiao; Xinwei Han
Journal:  J Cardiothorac Surg       Date:  2022-06-13       Impact factor: 1.522

4.  Effects of Recombinant Human Epidermal Growth Factor Eye Drops Combined with Phacoemulsification on Short- and Long-Term Visual Acuity Recovery and Related Dry Eye Complications in Patients with Senile Cataract.

Authors:  Lingzhi Fan; Tao He; Jiguang Shi; Xianlin Ke; Xiaolei Lu
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

5.  Efficacy of Human-Recombinant Epidermal Growth Factor Combined with Povidone-Iodine for Pressure Ulcers and Its Influence on Inflammatory Cytokines.

Authors:  Zunjiang Zhao; Dalun Lv; Baode Zhang; Liu Yong; Rongtao Zhang; Xiukun Wang
Journal:  Mediators Inflamm       Date:  2022-08-25       Impact factor: 4.529

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.